UPDATE 1-Biovail stock rises after new CEO named
628292
Analysts gave Biovail Corp.&#39;s (BVF.TO: Quote, Profile, Research) (BVF.N: Quote, Profile, Research) new chief executive a cautious welcome on Friday, but questioned
42207
The head of one of the world's largest funders of biomedical research is has said that he's set to substantially increase funding.
379166
The following is a short update from Alexander P. Cavasin, CEO of Alcar Chemicals Group Inc. (PINKSHEETS: ACMG).  With yesterday's announcement on the MOU I signed you have been able to see that there are some major developments taking place.
683291
Wall Street stocks were set for a higher start on Tuesday as Starbucks (NASDAQ:SBUX) and Bear Stearns (NYSE:BSC) prepared to appoint new chief executives and as soaring commodity prices were primed to boost stocks in the energy and mining sectors.
250310
Stock futures rose on Tuesday as news of an executive reshuffle at Starbucks Corp  sent the coffee chain's stock higher, while an advance in oil prices underpinned gains by energy companies.
564184
The company raises earnings guidance, boosting the stock.
104489
Shares in pharmaceutical company Elan soared in early trading this morning after a newspaper report that US company Biogen was considering a bid for the company.
122911
AOL Europe appoints new chief exec
113986
The Food and Drug Administration strongly endorsed Biogen Idec Inc.&#39;s new multiple sclerosis treatment, putting the Cambridge firm in position to expand the market for MS drugs and win greater market share.
28584
Blackstone Group LP, manager of the world's second-largest buyout fund, moved up its much-hyped $4.75 billion initial public offering to this week amid growing scrutiny of the firm on Capitol Hill and in the media.
97416
THE REGION Cambridge Drug maker Biogen Idec Inc. said it would start buying $3 billion worth of its own shares, potentially cutting the number of outstanding shares by one-sixth. Chief executive James Mullen said strong cash flows from sales of Avonex, for multiple sclerosis, and Rituxan, for non-Hodgkin's lymphoma, allowed the company to return money to shareholders in a tender ...
328042
NEW YORK, October 12  - The global pharmaceutical giant, Merck &amp; Company (MRK.NYS) plans to appoint a new CEO by the end of next year.
131461
Biovail Corp  has agreed to  drop a former Banc of America Securities analyst and the bank  itself as defendants in a lawsuit accusing nearly two dozen  parties of conspiring to drive down its stock price, the New  York Post reported in its online edition on Monday.
383698
TORONTO (CP) - Eugene Melnyk, who used his personal fortune to buy the Ottawa Senators last year, stepped aside Thursday as chief executive of Biovail Corp.
648390
CHESTERFORD RESEARCH PARK, U.K. and STOCKHOLM, Sweden, Sept. 22, 2004 (PRIMEZONE) -- BioFocus plc (AIM:BIO), a world leader in drug discovery, and Biovitrum today announce that Biovitrum has acquired from ...
59608
Standard &amp; Poor&#39;s Equity Research reiterated a &quot;hold&quot; rating and $68 target price on Biogen Idec (nasdaq: BIIB - news - people ), saying the anticipated success of the company&#39;s Antegren drug is largely factored into the share price.
687744
Shares of Boston Scientific (BSX:NYSE - news - research) rose Monday following the announcement that the Food and Drug Administration had approved its product to reduce the risk of a heart attack following heart bypass surgery.